Clinical Trials Directory

Trials / Unknown

UnknownNCT01979120

Validation of the "ApneaScan" Algorithm for the Detection of Sleep Disordered Breathing in Chronic Heart Failure

Validation of the "ApneaScan" Algorithm for the Detection of Sleep Disordered Breathing in Patients With Stable Symptomatic Chronic Heart Failure

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Dr. Christoph Schukro · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A prospective observational multi-centre study for the validation of the ApneaScan algorithm (integrated in ICD devices (with or without cardiac resynchronization therapy function) of the "Incepta" series for the screening of sleep disordered breathing in patients with stable symptomatic chronic heart failure, using portable polygraphy monitoring device ("Embletta Gold") as reference for the Apnea-Hypopnea-Index (AHI). Secondary objectives are the detection of severe sleep disordered breathing in patients with clinically indicated in-laboratory polysomnography, as well as correlations of the AHI detected by ApneaScan with other clinical endpoints like mortality, hospitalization, atrial fibrillation and ventricular arrhythmia.

Conditions

Timeline

Start date
2012-12-01
Primary completion
2014-08-01
First posted
2013-11-08
Last updated
2013-11-08

Locations

14 sites across 4 countries: Austria, Germany, Japan, Switzerland

Source: ClinicalTrials.gov record NCT01979120. Inclusion in this directory is not an endorsement.